![]() |
|
|
|
|
|
|
|
|
|
|
|
|
Indication: ALPHAGAN® P 0.1% ophthalmic solution is approved for the lowering of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
Important Safety Information Contraindication: ALPHAGAN® P 0.1% is contraindicated in patients receiving monoamine oxidase (MAO) inhibitor therapy. Precautions: Although ALPHAGAN® P 0.1% ophthalmic solution had minimal effect on the blood pressure of patients in clinical studies, caution should be exercised in treating patients with severe cardiovascular disease. ALPHAGAN® P 0.1% should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud's phenomenon, orthostatic hypotension, or thromboangiitis obliterans. Adverse reactions: Adverse events occurring in approximately 10% to 20% of the subjects included: allergic conjunctivitis, conjunctival hyperemia, and eye pruritus. Adverse events occurring in approximately 5% to 9% included: burning sensation, conjunctival folliculosis, hypertension, ocular allergic reaction, oral dryness, and visual disturbance. Please click here for full product information. 1. National Eye Institute. Facts about glaucoma. National Eye Institute Web site. http://www.nei.nih.gov/health/glaucoma/glaucoma_facts.asp. Accessed August 16, 2009. 2. Mayo Clinic. Risk factors. Mayo Clinic Web site. http://www.mayoclinic.com/health/glaucoma/DS00283/DSECTION=risk-factors. Accessed July 2, 2009. |
|
|
